Interleukin-10 promoter polymorphism in multiple sclerosis: association with disease progression

Area of Science:

• Immunogenetics
• Neuroimmunology
• Genetics of Autoimmune Diseases

Background:

• Interleukin-10 (IL-10) is a key immunosuppressive cytokine influencing multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE).
• Previous research identified microsatellite elements (IL-10.G and IL-10.R) upstream of the IL-10 gene, with alleles linked to IL-10 production levels.

Purpose of the Study:

• To investigate the association between IL-10 gene sequence variations (alleles and genotypes) and susceptibility to MS.
• To determine if these variations correlate with disease progression and severity in MS patients.

Main Methods:

• Genotyping analysis of IL-10.R and IL-10.G microsatellite alleles and genotypes in MS patients and healthy controls.
• Correlation of genotype data with multiple sclerosis disease severity, categorized by progression index (PI) into mild (PI < 0.5) and severe (PI > 0.5) groups.

Main Results:

• No significant association was found between the IL-10.R microsatellite and MS susceptibility or severity.
• Specific IL-10.G genotypes (G9/9, G10/13, G11/13, G13/14) were more frequent in MS patients with mild disease progression (p = 0.005).
• Other IL-10.G genotypes (G9/10, G9/11, G9/13, G12/13) were over-represented in MS patients with severe disease progression (p = 0.002).

Conclusions:

• Neither IL-10.R nor IL-10.G alleles are associated with predisposition to multiple sclerosis.
• Certain IL-10.G genotypes may serve as potential biomarkers for predicting MS disease progression.
• Further research is warranted to elucidate the functional role of these IL-10.G genotypes in MS pathogenesis.